The ABCs of sulfonylurea receptors, islet KATP channels and the control of insulin secretion

Canadian Journal of Diabetes

Volumn 26, Issue 3, 2002, Pages 223-231

  Light, Peter E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0141539668     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Nichols CG, Lederer WJ. Adenosine rriphosphate-sensitive potassium channels in the cardiovascular svstem. Am J Physiol. 1991;261:H1675-H1686.
2. + channel. Prog Neurobiol. 1993;41:21-30.
3. + channels in pancreatic, cardiac and vascular smooth muscle cells. Am J Physiol. 1998;274:C25-C37.
4. Dunne MJ, Harding EA, Jaggar H, Squires PE. Ion channels and the molecular control of insulin secretion. Biochem Soc Trans. 1994;22:6-12.
5. Dunne MJ, Petersen OH. Potassium selective ion channels in insulin-secreting cells: physiology, pharmacology and their role in stimulus-secretion coupling. Biochim Biophys Acta. 1991;1071:67-82.
6. + channel-opening drugs. Am J Physiol. 1995;269:C525-C545.
7. Nichols CG, Shyng SL, Nestorowicz A, et al. Adenosine diphosphate as an intracellular regulator of insulin secretion. Science. 1996;272:1785-1787.
8. Ashcroft FM, Proks P, Smith PA, et al. Stimulus-secretion coupling in pancreatic beta cells. J Cell Biochem. 1994;55(suppl):54-65.
9. Laghmich A, Ladriere L, Malaisse-Lagae F, Malaisse WJ. Longterm effects of glibenclamide and nateglinide upon pancreatic islet function in normal and diabetic rats. Pharmacol Res. 1999;40:475-482.
10. + channels in cardiac muscle. Nature. 1983;305:147-148.
11. + channels in pancreatic B cells. Nature. 1995;311:271-273.
12. Misler S, Falke LC, Gillis K, McDaniel ML. A metabolite-regulated potassium channel in rat pancreatic B cells. Proc Natl Acad Sci USA. 1986;83:7119-7123.
13. Ashcroft FM, Harrison DE, Ashcroft SJ. A potassium channel modulated by glucose metabolism in rat pancreatic beta-cells. Adv Exp Med Biol. 1986;21:53-62.
14. Ho K, Nichols CG, Lederer WJ, et al. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature. 1993;362:31-38.
15. ATP channel. Nature. 1994;370:456-459.
16. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of die beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995;268:423-426.
17. Inagaki N, Tsuura Y, Namba N, et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle and heart. J Biol Chem. 1995;270:5691-5694.
18. Seino S. ATP-sensitive potassium channels: a model of heteromultimeric potassium channel/receptor assemblies. Ann Rev Physiol. 1999;61:337-362.
19. Inagaki N, Gonoi T, Clement JP 4th, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270:1166-1170.
20. Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995;268:426-429.
21. Clement JP 4th, Kunjilwar K, Gonzalez G, et al. Association and stoichiometry of K(ATP) channel subunits. Neuron. 1997;18:827-838.
22. Bryan J, Aguilar-Bryan L. Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. Biochim Biophys Acta. 1999;1461:285-303.
23. Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev. 1999;79:S215-S255.
24. Tan B, Piwnica-Worms D, Ratner L. Multidrug resistance transporters and modulation. Curr Opin Oncol. 2000;12:450-458.
25. ATP channel: molecular cloning, expression and biological properties. Proc Natl Acad Sci USA. 1998;95:8387-8391.
26. ATP channels. Ann Rev Physiol. 1998;60:667-687.
27. Schwanstecher M, Schwanstecher C, Chudziak F, et al. ATP-sensitive potassium channels. Methods Enzynol. 1999;294:445-458.
28. + channels. Neuron. 1996;16:1011-1017.
29. Miki T, Liss B, Minami K, et al. ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci. 2001;4:507-512.
30. + channels linked to the green fluorescent protein in human embryonic kidney cells (HEK 293) J Physiol. 1998;510:333-345.
31. Tucker SJ, Gribble F, Zhao C, et al. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature. 1997;387:179-182.
32. Aguilar-Brvan L, Bryan J. ATP-sensitive potassium channels, sulfonylurea receptors, and persistent hyperinsulinemic hypoglycemia of infancy. Diabetes Reviews. 1996;4:336-346.
33. Koster JC, Marshall BA, Elisor N, et al. Targeted overactivity of beta-cell K(ATP) channels induces profound neonatal diabetes. Cell. 2000;100:645-654.
34. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev. 1999;20:876-913.
35. Vila Petroff MG, Egan JM. Wang X, Sollott SJ. Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res. 2001;89:445-452.
36. Leech CA, Holz GG, Habener JF. Signal transduction of PACAP and GLP-1 in pancreatic beta cells. Ann NY Acad Sci. 1996;805:81-92.
37. Byrne MM, Goke B. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use. Diabet Med. 1996;13:854-860.
38. Holz GG 4th, Kuhtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature. 1993;361:362-365.
39. Rachman J, Turner RC. Drugs on the horizon for treatment of type 2 diabetes. Diabet Med. 1995;12:467-478.
40. Gromada J, Holst JJ, Rorsman P. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Arch. 1998;435:583-594.
41. Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000;62:413-437.
42. Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic beta-cells. Am J Physiol. 2000;278:E1-E14.
43. + channels in pancreatic beta-cells. Diabetes. 1997;46:1087-1093.
44. ATP channel activation in the rat CRI-G1 insulinoma cell line. J Biol Chem. 2000;275:4660-4669.
45. + channels in the rat insulinoma cell line CRI-G1 J Physiol. 1998;510:47-61.
46. Sturgess NC, Ashford ML, Cook DL, Hales CN. The sulphonvlurea receptor may be an ATP-sensitive potassium channel. Lancet. 1985;2:474-475.
47. Smits P, Thien T. Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM? Diabetologia. 1995;38:116-121.
48. Smits P, Bijlstra PJ, Russel FG, et al. Cardiovascular effects of sulphonvlurea derivatives. Diabetes Res Clin Pract. 1996;31(suppl):S55-S59.
49. Garratt KN, Bradv PA, Hassinger NL, et al. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol. 1999;33:119-124.
50. Leibowitz G, Cerasi E. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia. 1996;39:503-514.
51. Reimann F, Proks P, Ashcroft FM. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel. Br J Pharmacol. 2001;132:1542-1548.
52. ATP channels to gliclazide. Diabetologia. 1999;42:845-848.
53. ATP channel blocker HMR 1883 reduces monophasic action potential shortening during coronary ischemia in anesthetised pigs. Naunyn Schmiedebergs Arch Pharmacol. 2000;361:155-160.
54. Gogelein H, Hartung J, Englert HC, Scholkens BA. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells. J Pharmacol Exp Ther. 1998;286:1453-1464.
55. ATP channels. Br J Pharmacol. 2002;135:480-488.
56. Dabrowski M, Wahl P, Holmes WE, Ashcroft FM. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels. Diabetologia. 2001;44:747-756.
57. ATP channel activity and membrane-binding studies with nateglinide: a comparison with sulfonylureas and repaglinide. J Pharmacol Exp Ther. 2000;293:444-452.
58. Hanif W, Kumar S. Nateglinide: a new rapid-acting insulinotropic agent. Expert Opin Pharmacother. 2001;2:1027-1031.
59. Braining GJ. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Op Pediatr. 1990;2:758-765.
60. Mathew PM, Young JM, Abu-Osba YK, et al. Persistent neonatal hyperinsulinism. Clin Pediatr. 1988;27:148-151.
61. Glaser B, Chiu KC, Anker R, et al. Familial hyperinsulinism maps to chromosome 11p14-15.1, 30 cM centromeric to the insulin gene. Nat Genet. 1994;7:185-188.
62. Sharma N, Crane A, Gonzalez G, et al. Familial hvperinsulinism and pancreatic p-cell ATP-sensitive potassium channels. Kidney Int. 2000;57:803-808.
63. + channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia. 1998;41:1511-1515.